Immunomodulatory Agents as Adjunctive Therapy for the Treatment of Resistant Candida Species.

Autor: Beyda, Nicholas, Regen, Sloan, Lewis, Russell, Garey, Kevin
Zdroj: Current Fungal Infection Reports; Jun2013, Vol. 7 Issue 2, p119-125, 7p
Abstrakt: Invasive Candida infections have increased fivefold over the past 20 years. During this time, the incidence of antifungal resistance and infection due to non- albicans species has risen with the increasing use of broad spectrum antifungals. As few new antifungal agents are in development, strategies to improve outcomes in the treatment of Candida infections are sorely needed. The use of immunotherapy to augment the host immune response as an adjunctive treatment for Candida infections is a potentially robust and promising approach. The purpose of this review is to focus on new developments in the use of adjunctive immunotherapy for the treatment of Candida infections, and discuss the potential impact of antifungal resistance on the host immune response. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index